Dendritic cells distinguish individual chemokine signals through CCR7 and CXCR4

Journal of Immunology

Volumn 186, Issue 1, 2011, Pages 53-61

  Ricart, Brendon G ^a   John, Beena ^b   Lee, Dooyoung ^a   Hunter, Christopher A ^b   Hammer, Daniel A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; G PROTEIN COUPLED RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MONOCYTE CHEMOTACTIC PROTEIN 5; MYOSIN II; PHOSPHATIDYLINOSITOL 3 KINASE; RAF PROTEIN; RAS PROTEIN; RHO FACTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; BONE MARROW; CELL HOMING; CELL MOTILITY; CHEMOKINESIS; CHEMOTAXIS; CONTROLLED STUDY; DENDRITIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; VELOCITY;

ACTINS; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINE CCL19; CHEMOKINE CXCL12; CHEMOTAXIS, LEUKOCYTE; DENDRITIC CELLS; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICROFLUIDIC ANALYTICAL TECHNIQUES; MYOSINS; RECEPTORS, CCR7; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION;

EID: 78751585802     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002358     Document Type: Article

References (56)

1. Randolph, G. J., V. Angeli, and M. A. Swartz. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5: 617-628.
2. Lämmermann, T., B. L. Bader, S. J. Monkley, T. Worbs, R. Wedlich-Söldner, K. Hirsch, M. Keller, R. Förster, D. R. Critchley, R. Fässler, and M. Sixt. 2008. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453: 51-55.
3. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
4. Lanzavecchia, A., and F. Sallusto. 2000. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290: 92-97.
5. Quaratino, S., L. P. Duddy, and M. Londei. 2000. Fully competent dendritic cells as inducers of T cell anergy in autoimmunity. Proc. Natl. Acad. Sci. USA 97: 10911-10916.
6. Jung, I. D., J. S. Lee, Y. J. Kim, Y.-I. Jeong, C.-M. Lee, M. G. Lee, S.-C. Ahn, and Y.-M. Park. 2007. Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen-activated protein kinase. Immunology 121: 533-544.
7. Sallusto, F., B. Palermo, D. Lenig, M. Miettinen, S. Matikainen, I. Julkunen, R. Forster, R. Burgstahler, M. Lipp, and A. Lanzavecchia. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29: 1617-1625.
8. Vecchi, A., L. Massimiliano, S. Ramponi, W. Luini, S. Bernasconi, R. Bonecchi, P. Allavena, M. Parmentier, A. Mantovani, and S. Sozzani. 1999. Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells. J. Leukoc. Biol. 66: 489-494.
9. Luster, A. D., R. L. Weinshank, R. Feinman, and J. V. Ravetch. 1988. Molecular and biochemical characterization of a novel gamma-interferon-inducible protein. J. Biol. Chem. 263: 12036-12043.
10. Proudfoot, A. E. 2002. Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2: 106-115.
11. De Smedt, T., B. Pajak, E. Muraille, L. Lespagnard, E. Heinen, P. De Baetselier, J. Urbain, O. Leo, and M. Moser. 1996. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184: 1413-1424.
12. Stockwin, L. H., D. McGonagle, I. G. Martin, and G. E. Blair. 2000. Dendritic cells: immunological sentinels with a central role in health and disease. Immunol. Cell Biol. 78: 91-102.
13. Yanagihara, S., E. Komura, J. Nagafune, H. Watarai, and Y. Yamaguchi. 1998. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 161: 3096-3102.
14. Luther, S. A., A. Bidgol, D. C. Hargreaves, A. Schmidt, Y. Xu, J. Paniyadi, M. Matloubian, and J. G. Cyster. 2002. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169: 424-433.
15. Förster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Müller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99: 23-33.
16. Gunn, M. D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L. T. Williams, and H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189: 451-460.
17. Gunn, M. D., K. Tangemann, C. Tam, J. G. Cyster, S. D. Rosen, and L. T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95: 258-263.
18. MartIn-Fontecha, A., S. Sebastiani, U. E. Höpken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198: 615-621.
19. Radstake, T. R., R. van der Voort, M. ten Brummelhuis, M. de Waal Malefijt, M. Looman, C. G. Figdor, W. B. van den Berg, P. Barrera, and G. J. Adema. 2005. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors. Ann. Rheum. Dis. 64: 359-367.
20. Chary, S. R., and R. K. Jain. 1989. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc. Natl. Acad. Sci. USA 86: 5385-5389.
21. Wilkinson, P. C. 1998. Assays of leukocyte locomotion and chemotaxis. J. Immunol. Methods 216: 139-153.
22. Ledgerwood, L. G., G. Lal, N. Zhang, A. Garin, S. J. Esses, F. Ginhoux, M. Merad, H. Peche, S. A. Lira, Y. Ding, et al. 2008. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat. Immunol. 9: 42-53.
23. Buettner, H. M., D. A. Lauffenburger, and S. H. Zigmond. 1989. Measurement of leukocyte motility and chemotaxis parameters with the Millipore filter assay. J. Immunol. Methods 123: 25-37.
24. Haessler, U., Y. Kalinin, M. A. Swartz, and M. Wu. 2009. An agarose-based microfluidic platform with a gradient buffer for 3D chemotaxis studies. Biomed. Microdevices 11: 827-835.
25. Kim, D., M. A. Lokuta, A. Huttenlocher, and D. J. Beebe. 2009. Selective and tunable gradient device for cell culture and chemotaxis study. Lab Chip 9: 1797-1800.
26. Jannat, R. A., M. Dembo, D. A. Hammer, and D. A. Hammer. 2010. Neutrophil adhesion and chemotaxis depend on substrate mechanics. J. Phys. Condens. Matter 22: 194117.
27. Herzmark, P., K. Campbell, F. Wang, K. Wong, H. El-Samad, A. Groisman, and H. R. Bourne. 2007. Bound attractant at the leading vs. the trailing edge determines chemotactic prowess. Proc. Natl. Acad. Sci. USA 104: 13349-13354.
28. Irimia, D., S.-Y. Liu, W. G. Tharp, A. Samadani, M. Toner, and M. C. Poznansky. 2006. Microfluidic system for measuring neutrophil migratory responses to fast switches of chemical gradients. Lab Chip 6: 191-198.
29. Li Jeon, N., H. Baskaran, S. K. W. Dertinger, G. M. Whitesides, L. Van de Water, and M. Toner. 2002. Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat. Biotechnol. 20: 826-830.
30. Lin, F., C. M.-C. Nguyen, S.-J. Wang, W. Saadi, S. P. Gross, and N. L. Jeon. 2005. Neutrophil migration in opposing chemoattractant gradients using microfluidic chemotaxis devices. Ann. Biomed. Eng. 33: 475-482.
31. Lin, F., and E. C. Butcher. 2006. T cell chemotaxis in a simple microfluidic device. Lab Chip 6: 1462-1469.
32. Lutz, M. B., N. Kukutsch, A. L. J. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
33. Xia, Y., and G. M. Whitesides. 1998. Soft Lithography. Annu. Rev. Mater. Sci. 28: 153-184.
34. Jannat, R. A, M. Dembo, and D. A. Hammer. 2010. Neutrophil adhesion and chemotaxis depend on substrate mechanics. J. Phys. Condens. Matter 22: 194117.
35. Lauffenburger, D. A., and J. J. Linderman. 1996. Receptors: Models for Binding, Trafficking, and Signaling. Oxford University Press, New York.
36. Ford, R. M., and D. A. Lauffenburger. 1991. Measurement of bacterial random motility and chemotaxis coefficients: II. Application of single-cell-based mathematical model. Biotechnol. Bioeng. 37: 661-672.
37. Steinman, R. M., S. Turley, I. Mellman, and K. Inaba. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191: 411-416.
38. Robbiani, D. F., R. A. Finch, D. Jäger, W. A. Muller, A. C. Sartorelli, and G. J. Randolph. 2000. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103: 757-768.
39. Chernyavsky, A. I., J. Arredondo, E. Karlsson, I. Wessler, and S. A. Grando. 2005. The Ras/Raf-1/MEK1/ERK signaling pathway coupled to integrin expression mediates cholinergic regulation of keratinocyte directional migration. J. Biol. Chem. 280: 39220-39228.
40. Vindis, C., D. P. Cerretti, T. O. Daniel, and U. Huynh-Do. 2003. EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis. J. Cell Biol. 162: 661-671.
41. Yoo, S. K., Q. Deng, P. J. Cavnar, Y. I. Wu, K. M. Hahn, and A. Huttenlocher. 2010. Differential regulation of protrusion and polarity by PI3K during neutrophil motility in live zebrafish. Dev. Cell 18: 226-236.
42. Renkawitz, J., K. Schumann, M. Weber, T. Lämmermann, H. Pflicke, M. Piel, J. Polleux, J. P. Spatz, and M. Sixt. 2009. Adaptive force transmission in amoeboid cell migration. Nat. Cell Biol. 11: 1438-1443.
43. Faure-André, G., P. Vargas, M.-I. Yuseff, M. Heuzé, J. Diaz, D. Lankar, V. Steri, J. Manry, S. Hugues, F. Vascotto, et al. 2008. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science 322: 1705-1710.
44. Schumann, K., T. Lämmermann, M. Bruckner, D. F. Legler, J. Polleux, J. P. Spatz, G. Schuler, R. Förster, M. B. Lutz, L. Sorokin, and M. Sixt. 2010. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 32: 703-713.
45. Yoshida, R., M. Nagira, M. Kitaura, N. Imagawa, T. Imai, and O. Yoshie. 1998. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J. Biol. Chem. 273: 7118-7122.
46. Mori, S., H. Nakano, K. Aritomi, C.-R. Wang, M. D. Gunn, and T. Kakiuchi. 2001. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J. Exp. Med. 193: 207-218.
47. Junt, T., E. Scandella, R. Förster, P. Krebs, S. Krautwald, M. Lipp, H. Hengartner, and B. Ludewig. 2004. Impact of CCR7 on priming and distribution of antiviral effector and memory CTL. J. Immunol. 173: 6684-6693. (Pubitemid 39541053)
48. Ohl, L., G. Bernhardt, O. Pabst, and R. Förster. 2003. Chemokines as organizers of primary and secondary lymphoid organs. Semin. Immunol. 15: 249-255.
49. Foxman, E. F., J. J. Campbell, and E. C. Butcher. 1997. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 139: 1349-1360.
50. Kohout, T. A., S. L. Nicholas, S. J. Perry, G. Reinhart, S. Junger, and R. S. Struthers. 2004. Differential desensitization, receptor phosphorylation, b-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J. Biol. Chem. 279: 23214-23222.
51. Britschgi, M. R., A. Link, T. K. A. Lissandrin, and S. A. Luther. 2008. Dynamic modulation of CCR7 expression and function on naive T lymphocytes in vivo. J. Immunol. 181: 7681-7688.
52. Otero, C., M. Groettrup, and D. F. Legler. 2006. Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation. J. Immunol. 177: 2314-2323.
53. Byers, M. A., P. A. Calloway, L. Shannon, H. D. Cunningham, S. Smith, F. Li, B. C. Fassold, and C. M. Vines. 2008. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. J. Immunol. 181: 4723-4732.
54. Reif, K., E. H. Ekland, L. Ohl, H. Nakano, M. Lipp, R. Förster, and J. G. Cyster. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416: 94-99.
55. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.-L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J.-M. Heard, I. Clark-Lewis, D. F. Legler, et al. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382: 833-835.
56. Laguri, C., R. Sadir, P. Rueda, F. Baleux, P. Gans, F. Arenzana-Seisdedos, and H. Lortat-Jacob. 2007. The novel CXCL12γ isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. PLoS ONE 2: e1110.